Orsiro™ Drug Eluting Stent in Routine Clinical Practice
NCT ID: NCT02039739
Last Updated: 2023-06-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1007 participants
OBSERVATIONAL
2014-06-30
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Orsiro Drug Eluting Stent System
NCT01356888
First in Man Experience With a Drug Eluting Stent in De Novo Coronary Artery Lesions
NCT01214148
BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions
NCT01426139
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT02389946
Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent
NCT01826552
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Orsiro™ Drug Eluting Stent
Orsiro™ Drug Eluting Stent group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Orsiro™ Drug Eluting Stent group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intervention with Orsiro™ Drug Eluting Stent
* Agreed with written informed consent form
Exclusion Criteria
* Life expectancy of 1year and under
* Cardiac shock
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CardioVascular Research Foundation, Korea
OTHER
Biotronik Korea Co., Ltd
INDUSTRY
Seung-Jung Park
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seung-Jung Park
MD,PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hallym University Sacred Heart Hospital
Anyang, , South Korea
Soon Chun Hyang University Hospital Bucheon
Bucheon-si, , South Korea
Dankook University Hospital
Cheonan, , South Korea
Soon Chun Hyang University Hospital Cheonan
Cheonan, , South Korea
Gangwon National Univ. Hospital
Chuncheon, , South Korea
Daegu Catholic University Medical Center
Daegu, , South Korea
Keimyung University Dongsan Medical Center
Daegu, , South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, , South Korea
Gangneung Asan Hospital
Gangneung, , South Korea
Chonnam National University Hospital
Gwangju, , South Korea
Gachon University Gil Hospital
Incheon, , South Korea
Inje University Pusan Paik Hospital
Pusan, , South Korea
Pusan National University Yangsan Hospital
Pusan, , South Korea
Asan Medical Center
Seoul, , South Korea
Gangnam Severance Hospital
Seoul, , South Korea
Kangdong Sacred Heart Hospital
Seoul, , South Korea
Korea University Guro Hospital
Seoul, , South Korea
Ulsan University Hospital
Ulsan, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AMCCV2014-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.